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Abstract
Background: Even though data suggest that palliative care (PC) improves patient quality of life, caregiver burden, cost,
and intensive care unit (ICU) length of stay, integration of PC in the ICU is far from being universally accepted. Poor
understanding of what PC provides is one of the barriers to the widespread implementation of their services in ICU.
Evidence suggests that the availability of specialist PC is lacking in most European countries and provided differently
depending on geographical location. The aim of this systematic review is to compare the numbers and types of PC
interventions and gauge their impact on stakeholder outcomes and ICU resource utilisation.
Methods: We will undertake a systematic review of the published peer-reviewed journal articles; our search will be
carried out MEDLINE, Embase, Cochrane, CINAHL, and PsycINFO. The search strategy will include variations in the term
‘palliative care’ and ‘intensive care’. All studies with patient populations undergoing palliative care interventions will be
selected. Only full-text articles will be considered, and conference abstracts excluded. There will be no date restrictions
on the year of publications or on language. The primary aim of the present study is to compare the numbers and
types of PC interventions in ICU and their impact on stakeholder (patient, family, clinician, other) outcomes. Reporting
of findings will follow the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Discussion: This review will provide insight into the implementation of palliative care in ICU, elucidate differences
between countries and health systems, reveal most effective models, and contribute to identifying research priorities to
improve outcomes.
Systematic review registration: International Prospective Register of Systematic reviews PROSPERO
(CRD42018094315)
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Background
Palliative care (PC) is a holistic approach which incorpo-
rates management of physical, psychological and spiritual
symptoms, communication regarding goals of care, support
for clinicians and families, and planning for care transitions
in patients with critical illness [1]. Even though data suggest
that PC improves quality of life, and decreases caregiver
burden, cost [2, 3], and hospital and intensive care unit
(ICU) length of stay [4], the integration of PC in the ICU is
not universally accepted. Poor understanding of what PC
provides is one of the barriers to the widespread implemen-
tation of their services [5] in ICU. Evidence suggests that
specialist PC is lacking from most European countries and
provided differently depending on geographical location [6].
This is further complicated by the fact that end-of-life
(EoL) practices also vary between countries and healthcare
systems. For instance, EoL care is more hospital-centric in
the USA than in Europe, although ICU admissions in the
last days of life are more prevalent in Europe compared to
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the USA [7]. Three separate models have been proposed to
aid better PC-ICU integration: improving palliative care by
ICU clinicians, as part of routine ICU practice (integrative
model); improving palliative care by utilising specialist PC
teams (consultative model); and a mixed model that incor-
porates both of these strategies.
Recently, existing evidence was organised to address:
(1) opportunities to alleviate physical and emotional
symptoms, improve communication, and provide sup-
port for patients and families; (2) models and specific in-
terventions for improving ICU palliative care; (3)
available resources for ICU palliative care improvement;
and (4) ongoing challenges and targets for future re-
search [8]. However, the methods and specific tools used
to assess the impact of PC in ICU are varied [9, 10]. Fur-
thermore, previous studies in PC have used hetero-
geneous outcomes that often fail to capture the
multi-dimensional nature of the discipline and the
varied needs of different stakeholders [4]. The most
effective and efficient way to provide PC in ICU is
largely unknown [8].
The aim of this systematic review was to compare
the numbers and types of PC interventions and
gauge their impact on stakeholder outcomes and
ICU resource utilisation.
Objectives
The primary aim of this study is to compare the num-
bers and types of PC interventions in ICU, and their im-
pact on patient and family outcomes.
Secondary aims are to
 Assess the models for integrating palliative care into
the ICU
 Compare evidence from different regions of the
world (Europe, North America, South America,
Asia).
This will enable us to identify research priorities
and formulate a research agenda to improve palliative
care in ICU.
Methods
In order to assess the current state of evidence, we
propose to describe the numbers and types of PC in-
terventions and gauge their impact on stakeholder
(patients, families, and healthcare providers) out-
comes and ICU resource utilisation. We also intend
to assess the different types of PC and their variable
integration in European versus non-European coun-
tries and provide data to develop future interven-
tions to improve PC in the ICU.
Data sharing
This systematic review protocol is registered with
the PROSPERO International Prospective Register of
Systematic Reviews (https://www.crd.york.ac.uk/pros-
pero/display_record.php?RecordID=94315)
(CRD42018094315) and will be reported using Pre-
ferred Reporting Items of Systematic Reviews and
Meta-Analyses (PRISMA) guidelines in the peer-
reviewed literature [11].
PICO question
We have undertaken a systematic review of the pub-
lished peer-reviewed journal articles. We have defined
the PICOS criteria as follows:
Population
Adult patients (> 18 years of age) admitted to the inten-
sive care unit or high-dependency areas.
Terms used:
(burn unit*[tiab] OR coronary care unit*[tiab] OR re-
spiratory care unit*[tiab] OR intensive cardiac care [tiab]
OR “Intensive Care Units”[Mesh:NoExp] OR icu [tiab]
OR high dependency unit [tiab] OR hdu [tiab]) OR
“Burn Units”[Mesh] OR “Coronary Care Units”[Mesh]
OR “Respiratory Care Units”[Mesh].
Intervention
Palliative care interventions occurring in ICU.
Terms used:
(“Palliative Care”[Mesh] OR “Palliative Medicine”[-
Mesh] OR “Hospice and Palliative Care Nursing”[Mesh]
OR “Terminal Care”[Mesh] OR “Hospice Care”[Mesh]
OR palliat*[tiab] OR eol care [tiab] OR EOLC [tiab] OR
terminal care [tiab] OR end of life [tiab] OR terminal ill-
ness [tiab] OR terminal patient*[tiab] OR terminally ill
[tiab] OR limited survival [tiab] OR critically ill [tiab]
OR terminal phase [tiab] OR terminal stage [tiab] OR
life-limiting [tiab] OR bereavement care [tiab] OR be-
reavement care [tiab] OR bereavement counselling [tiab]
OR comfort care [tiab] OR symptom management [tiab]
OR symptomatic treatment [tiab] OR symptomatic ther-
apy [tiab] OR hospice program*[tiab] OR hospice care
[tiab] OR limited life [tiab] OR supportive care [tiab] OR
supportive need*[tiab] OR supportive treatment [tiab]
OR supportive therapy [tiab])
Comparator
Patients that did not receive any PC interventions.
Terms used: none.
Outcome
The number and type of PC interventions as identi-
fied by a working group funded by the Robert Wood
Johnson Foundation (patient- and family-centred care,
Metaxa et al. Systematic Reviews           (2019) 8:148 Page 2 of 5
communication, continuity of care, emotional and
practical support of patients and families, symptom
management and comfort care, spiritual support, and
emotional and organisational support for ICU clini-
cians) in ICU in Europe, North America, South
America, and Asia [12]. We will also assess the effect
of these interventions on the domains of patient/fam-
ily-, clinician-, systems-, content-related outcomes,
evaluating the different PC models.
Terms used: none.
Studies
Controlled trials (randomised and non-randomised).
Case reports, case series, editorials/commentaries, opin-
ion papers, studies with no outcome data, small studies
(< 30 patients), publications only as abstracts, and (non-
systematic) review papers will not be included.
Terms used:
((randomised controlled trial [pt] OR controlled clinical
trial [pt] OR randomised controlled trials [mh] OR ran-
dom allocation [mh] OR double-blind method [mh] OR
single-blind method [mh] OR clinical trial [pt] OR clinical
trials [mh] OR “clinical trial”[tw] OR ((singl*[tw] OR
doubl*[tw] OR trebl*[tw] OR tripl*[tw]) AND (mask*[tw]
OR blind*[tw])) OR “latin square”[tw] OR placebos [mh]
OR placebo*[tw] OR random*[tw] OR research design
[mh:noexp] OR comparative study [pt] OR evaluation
studies [pt] OR follow-up studies [mh] OR prospective
studies [mh] OR cross-over studies [mh] OR control [tw]
OR controll*[tw] OR prospectiv*[tw] OR volunteer*[tw])
NOT (animals [mh] NOT humans [mh]))
OR
Systematic [sb].
The search terms above are specific to PubMed/MED-
LINE and will not generalise to other search engines.
Search strategies for the other databases were derived
from the terms used in PubMed.
Information sources and search strategy
With the assistance of a librarian, we designed a Boolean
search strategy which includes variations in the term ‘pal-
liative care’ and ‘intensive care’. We carried out the search
strategy on the following databases: MEDLINE, EMBASE,
Cochrane, CINAHL, and PsycINFO. The search terms
that were used are outlined above. There were no date re-
strictions on the year of publications or on language. The
preliminary peer review/scoping of the literature was con-
ducted between 02 February 2018 and 19 May 2018. The
formal systematic search of the literature was completed
on 19 May 2018. The systematic search was conducted by
a professional librarian (IvD) and assisted by three of the
content experts (VM, DA, and SV).
Inclusion and exclusion criteria
Inclusion criteria:
1. All adult patients (> 18 years of age) admitted to the
intensive care unit
2. Palliative care intervention
Exclusion criteria include the following:
1. (Paediatric) populations
2. Case series
3. Opinion paper/commentary
4. Review article (non-systematic review)
5. Lack of quantitative data
6. < 30 patients in study population
7. Conference abstracts/grey literature
Study selection
After retrieving initial results, results were amalgamated
and duplicates removed using RefWorks. The remaining
studies were loaded onto the online systematic review
software Covidence™. There was a total of five independ-
ent reviewers (VM, SV, DA, NA, and SB) who independ-
ently performed the title and abstract screening. Each
title/abstract was reviewed independently by two re-
viewers. Where there was disagreement between re-
viewers, conflict was resolved between the two reviewers,
erring on the side of inclusivity. A fifth author was con-
sulted where consensus is not reached. Full texts will be
retrieved for inclusion based upon the defined criteria.
We will screen the references of included studies for po-
tential publications not identified by the search strategy.
Outcome measures
Our main objectives are to establish the number, type,
and effectiveness of PC interventions in ICU, and to as-
certain differences between Europe, North America,
South America, and Asia. We will attempt to categorise
outcomes of PC interventions according to previously
established domains (patient- and family- centred care,
communication, continuity of care, emotional and prac-
tical support of patients and families, symptom manage-
ment and comfort care, spiritual support, and emotional
and organisational support for ICU clinicians), to cir-
cumvent variations in terminology. We will also endeav-
our to assess the models for integrating palliative care
into the ICU, identify research priorities, and formulate
a research agenda to improve palliative care in ICUs.
Data extraction
Data will be extracted onto a customised data extraction
sheet by two independent reviewers. Conflicts will be re-
solved by discussion between the reviewing authors. A third
author will be consulted where consensus is not reached.
Metaxa et al. Systematic Reviews           (2019) 8:148 Page 3 of 5
Variables to be extracted will include but not be limited to
 Study data: year of data collection, year of publication,
type of study, country of study, first author name,
journal, total number of patients, clinical setting, and
primary and secondary outcomes
 Patient population data: age, primary diagnosis, sex,
life-limiting condition
 Palliative care intervention data: palliative care
consults, end-of-life care, terminal care, advance
care planning, living wills, ethics consultation, family
meetings, and symptom management
 Outcome data: data including but not limited to:
patient/family-, clinician-, system-, and content-
related factors. These include patient- and family-
centred care, communication, continuity of care,
emotional and practical support of patients and fam-
ilies, symptom management and comfort care, spirit-
ual support, and emotional and organisational
support for ICU clinicians.
Where the study data is missing, we will attempt to
contact the corresponding author.
Evaluation of methodological quality of studies
Methodological quality of included randomised control
trials will be assessed using Cochrane Collaboration’s tool
for assessing risk of bias [13]. The following domains will
be assessed for randomised controlled trials: random se-
quence generation, allocation concealment, blinding of se-
quence generation, allocation concealment, blinding of
participants and personnel, blinding of outcome assess-
ment, incomplete outcome data, selective reporting, and
other bias. The risk of bias in each domain will be judged
as either low, moderate, high, or unclear.
Methodological quality of included non-randomised
trials will be assessed using the ROBINS-I tool. Seven
domains of bias will be assessed including confounding,
selection bias, bias in measurement classification of in-
terventions, bias due to deviations from intended inter-
ventions, bias due to missing data, bias in measurement
outcomes, and bias in selection of the reported result
[14]. The risk of bias in each domain will be judged as
either low, moderate, high, critical, or unclear.
To assess the risk of bias, we will rely on the informa-
tion presented in the published literature. No reviewer
will assess risk of bias for manuscripts they have partici-
pated in as an author.
Analysis of outcomes
The initial analysis will be of a descriptive nature. The pal-
liative care interventions and outcomes will be described.
Subgroup analyses will include PC intervention incidence
by region (Europe, North America, South America, and
Asia). Where there is homogeneity between studies in the
palliative care interventions used and measured outcomes,
we will compare outcomes.
We will use the Mantel-Haenszel models for all dichot-
omous outcomes and we used the inverse variance
method for the continuous outcomes. For continuous
measures, we will calculate the mean differences. A ran-
dom effects model will be used to analyse the data. Results
will be presented as odds ratios with 95% confidence inter-
vals for dichotomous outcomes. The meta-analysis will be
carried out using review manager (‘Revman’) for Mac (ver-
sion 5.1, Cochrane Collaboration, Oxford, UK). Statistical
heterogeneity will be assessed using the I2 methodology. I2
values > 50% and > 75% are considered to indicate moder-
ate and significant heterogeneity among studies, respect-
ively. All p values will be two-tailed and considered
statistically significant if < 0.05.
The strength of the body of evidence will be addressed
using the GRADE (Grades of Recommendation Assess-
ment, Development and Evaluation) system [15]. Any
amendments to the protocol will be explicitly stated in the
methods section of the final systematic review manuscript.
Formulation of the recommendations
We will conduct a modified Delphi process to develop
further recommendations for clinical practice and future
clinical trials. The first step will consist of the working
group developing draft recommendations; then, for the
subsequent Delphi steps, we anticipate expanding to 20–
25 members of the European Society of Intensive Care
(ESICM) Ethics Committee with broad geographic
(country) representation.
Discussion
Patients admitted in ICU are often at high risk of dying
and require invasive interventions or intensive monitor-
ing. Among survivors, long-lasting sequelae affect pa-
tients’ quality of life, resulting in physical, cognitive and
psychosocial complications [16]. Palliative care integrates
the management of physical, psychological and spiritual
symptoms, communication regarding goals of care, sup-
port for clinicians and families, and planning for care
transitions in patients with a critical illness. PC is there-
fore an important component of ICU care for many pa-
tients, despite the traditional view that they constitute
mutually exclusive forms of care. This view is more
prevalent in Europe, where often the End-of-Life (EoL)
needs of patients in ICU are addressed by intensivists,
not palliative care specialists. The models for providing
PC differ according to geographic and cultural criteria,
rendering the comparison of outcomes problematic.
Integration of palliative care in ICU has been the topic
of extensive research in the recent years. Previous system-
atic reviews have highlighted the heterogeneity of the PC
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interventions and the lack of consistent meaningful, multi-
faceted outcomes. We aim to bring together the evidence
behind diverse interventions and outcomes of palliative
care interventions in intensive care. This will facilitate the
identification of key interventions which are consistently
associated with positive clinical outcomes. Equally, we
may be able to identify the lack of evidence behind specific
interventions and outcomes that are potentially useful.
This process will enable clinicians and researchers to iden-
tify the best interventions and outcomes for future clinical
trials.
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